世界のクリティカルケア診断市場2020-2024

◆英語タイトル:Global Critical Care Diagnostics Market 2020-2024
◆商品コード:IRTNTR43701
◆発行会社(リサーチ会社):Technavio
◆発行日:2020年5月27日
◆ページ数:約120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア、その他
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥312,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥416,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートではクリティカルケア診断の世界市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、用途別(微生物・感染症検査、血液検査、心臓・脂質検査、凝固検査、その他)分析、エンドユーザー別(救急治療室、手術室、ICU)分析、顧客状況、地域別状況、企業状況、企業分析などを総合的、多面的に調査・分析しました。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・クリティカルケア診断の世界市場:用途別(微生物・感染症検査、血液検査、心臓・脂質検査、凝固検査、その他)
・クリティカルケア診断の世界市場:エンドユーザー別(救急治療室、手術室、ICU)
・顧客状況
・地域別状況
・企業状況
・企業分析
【レポートの概要】

Global Critical Care Diagnostics Market 2020-2024

Technavio has been monitoring the critical care diagnostics market and it is poised to grow by USD 1.72 bn during 2020-2024 progressing at a CAGR of 17% during the forecast period. Our reports on critical care diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing number of M&As and rise in the number of hospitals. In addition, focus on the diagnosis of infectious diseases is anticipated to boost the growth of the market as well.

The critical care diagnostics market analysis includes end-user segment, application and geographic landscape.
Technavio’s critical care diagnostics market is segmented as below:
By End-user
• Emergency care units
• Operating rooms
• ICUs

By Application
• Microbial and infectious disease testing
• Hematology testing
• Cardiac and lipid testing
• Coagulation testing
• Others

By Geographic Landscape
• North America
• Europe
• Asia
• ROW

This study identifies the data management and connectivity to EHRs through interoperability as one of the prime reasons driving the critical care diagnostics market growth during the next few years. Also, focus on next-generation technologies and increasing online marketing of critical care diagnostics will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our critical care diagnostics market covers the following areas:
• Critical care diagnostics market sizing
• Critical care diagnostics market forecast
• Critical care diagnostics market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading critical care diagnostics market vendors that include Abbott Laboratories, Becton, Dickinson and Co., bioMérieux SA, Bio-Rad Laboratories Inc., Chembio Diagnostics Inc., Danaher Corp., EKF Diagnostics Holdings Plc, F. Hoffmann-La Roche Ltd., Quidel Corp., and Siemens Healthineers AG. Also, the critical care diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/global-critical-care-diagnostics-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Application
o Market segments
o Comparison by Application
o Microbial and infectious disease testing – Market size and forecast 2019-2024
o Hematology testing – Market size and forecast 2019-2024
o Cardiac and lipid testing – Market size and forecast 2019-2024
o Coagulation testing – Market size and forecast 2019-2024
o Others – Market size and forecast 2019-2024
o Market opportunity by Application
• Market Segmentation by End-users
o Emergency care units
o Operating rooms
o ICUs
• Customer Landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o Asia – Market size and forecast 2019-2024
o ROW – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
o Competitive scenario
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Abbott Laboratories
o bioMérieux SA
o Bio-Rad Laboratories Inc.
o Chembio Diagnostics Inc.
o Danaher Corp.
o EKF Diagnostics Holdings Plc
o F. Hoffmann-La Roche Ltd.
o Quidel Corp.
o Siemens Healthineers AG
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2019 – 2024 ($ million)
• 13: Global market: Year-over-year growth 2019 – 2024 (%)
• 14: Five forces analysis 2019 & 2024
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2019
• 21: Application – Market share 2019-2024 (%)
• 22: Comparison by Application
• 23: Microbial and infectious disease testing – Market size and forecast 2019-2024 ($ million)
• 24: Microbial and infectious disease testing – Year-over-year growth 2019-2024 (%)
• 25: Hematology testing – Market size and forecast 2019-2024 ($ million)
• 26: Hematology testing – Year-over-year growth 2019-2024 (%)
• 27: Cardiac and lipid testing – Market size and forecast 2019-2024 ($ million)
• 28: Cardiac and lipid testing – Year-over-year growth 2019-2024 (%)
• 29: Coagulation testing – Market size and forecast 2019-2024 ($ million)
• 30: Coagulation testing – Year-over-year growth 2019-2024 (%)
• 31: Others – Market size and forecast 2019-2024 ($ million)
• 32: Others – Year-over-year growth 2019-2024 (%)
• 33: Market opportunity by Application
• 34: Customer landscape
• 35: Market share by geography 2019-2024 (%)
• 36: Geographic comparison
• 37: North America – Market size and forecast 2019-2024 ($ million)
• 38: North America – Year-over-year growth 2019-2024 (%)
• 39: Europe – Market size and forecast 2019-2024 ($ million)
• 40: Europe – Year-over-year growth 2019-2024 (%)
• 41: Asia – Market size and forecast 2019-2024 ($ million)
• 42: Asia – Year-over-year growth 2019-2024 (%)
• 43: ROW – Market size and forecast 2019-2024 ($ million)
• 44: ROW – Year-over-year growth 2019-2024 (%)
• 45: Key leading countries
• 46: Market opportunity by geography ($ million)
• 47: Impact of drivers and challenges
• 48: Vendor landscape
• 49: Landscape disruption
• 50: Industry risks
• 51: Vendors covered
• 52: Market positioning of vendors
• 53: Abbott Laboratories – Overview
• 54: Abbott Laboratories – Business segments
• 55: Abbott Laboratories – Key offerings
• 56: Abbott Laboratories – Key customers
• 57: Abbott Laboratories – Segment focus
• 58: Becton, Dickinson and Co. – Overview
• 59: Becton, Dickinson and Co. – Business segments
• 60: Becton, Dickinson and Co. – Key offerings
• 61: Becton, Dickinson and Co. – Key customers
• 62: Becton, Dickinson and Co. – Segment focus
• 63: bioMérieux SA – Overview
• 64: bioMérieux SA – Business segments
• 65: bioMérieux SA – Key offerings
• 66: bioMérieux SA – Key customers
• 67: bioMérieux SA – Segment focus
• 68: Bio-Rad Laboratories Inc. – Overview
• 69: Bio-Rad Laboratories Inc. – Business segments
• 70: Bio-Rad Laboratories Inc. – Key offerings
• 71: Bio-Rad Laboratories Inc. – Key customers
• 72: Bio-Rad Laboratories Inc. – Segment focus
• 73: Chembio Diagnostics Inc. – Overview
• 74: Chembio Diagnostics Inc. – Business segments
• 75: Chembio Diagnostics Inc. – Key offerings
• 76: Chembio Diagnostics Inc. – Key customers
• 77: Chembio Diagnostics Inc. – Segment focus
• 78: Danaher Corp. – Overview
• 79: Danaher Corp. – Business segments
• 80: Danaher Corp. – Key offerings
• 81: Danaher Corp. – Key customers
• 82: Danaher Corp. – Segment focus
• 83: EKF Diagnostics Holdings Plc – Overview
• 84: EKF Diagnostics Holdings Plc – Business segments
• 85: EKF Diagnostics Holdings Plc – Key offerings
• 86: EKF Diagnostics Holdings Plc – Key customers
• 87: EKF Diagnostics Holdings Plc – Segment focus
• 88: F. Hoffmann-La Roche Ltd. – Overview
• 89: F. Hoffmann-La Roche Ltd. – Business segments
• 90: F. Hoffmann-La Roche Ltd. – Key offerings
• 91: F. Hoffmann-La Roche Ltd. – Key customers
• 92: F. Hoffmann-La Roche Ltd. – Segment focus
• 93: Quidel Corp. – Overview
• 94: Quidel Corp. – Business segments
• 95: Quidel Corp. – Key offerings
• 96: Quidel Corp. – Key customers
• 97: Quidel Corp. – Segment focus
• 98: Siemens Healthineers AG – Overview
• 99: Siemens Healthineers AG – Business segments
• 100: Siemens Healthineers AG – Key offerings
• 101: Siemens Healthineers AG – Key customers
• 102: Siemens Healthineers AG – Segment focus
• 103: Currency conversion rates for US$
• 104: Research Methodology
• 105: Validation techniques employed for market sizing
• 106: Information sources
• 107: List of abbreviations



【掲載企業】

Abbott Laboratories, Becton, Dickinson and Co., bioMérieux SA, Bio-Rad Laboratories Inc., Chembio Diagnostics Inc., Danaher Corp., EKF Diagnostics Holdings Plc, F. Hoffmann-La Roche Ltd., Quidel Corp., Siemens Healthineers AG

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のクリティカルケア診断市場2020-2024]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆